NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical nerve stimulation with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same.”

As quoted in the press release:

This patent covers our novel technology that enhances Quell^® device performance for users with an active lifestyle.

“We are pleased to have received this latest patent, which further expands the Quell intellectual property portfolio and creates an important competitive advantage for our Wearable Pain Relief Technology,” said Shai N. Gozani, M.D., Ph.D. “Maintaining an active lifestyle is important for chronic pain management and the technology described in this patent allows even the most active users to easily and intuitively interact with their Quell device.”

Click here to read the full press release.